Journal of Thoracic Oncology Journal
Overview
Publication venue for
- Real-World Data and Racial Outcomes for NSCLC in The Chemo-Immunotherapy Era. 16:S1076-S1077. 2021
- The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers. 16:S879-S879. 2021
- Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. 15:1577-1598. 2020
- Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. 15:1577-1598. 2020
- A Phase II Trial of Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Neuroendocrine Carcinoma. 14:S813-S814. 2019
- NET-001: A Phase II Study of ABI-009 in Metastatic Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System. 14:S1023-S1023. 2019
- Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers. 14:S6-S7. 2019
- Pulmonary Neuroendocrine (Carcinoid) Tumors: CommNETs/NANETS Endorsement and Update of the ENETs Best Practice Consensus. 13:S575-S575. 2018
- Utility of Stereotactic Body Radiotherapy in Pulmonary Carcinoid Tumors. 13:S793-S793. 2018
- ABOUND.PS2: Safety and Efficacy of Nab-Paclitaxel-Based Therapy in Patients with NSCLC and ECOG PS 2. 12:S2073-S2073. 2017
- Longitudinal Assessment of Performance Status (PS) in Patients with NSCLC and ECOG PS 2 on Nab-Paclitaxele-Based Therapy. 12:S2073-S2074. 2017
- ABOUND.PS2 Interim Safety Results: nab-Paclitaxel/Carboplatin Followed by nab-Paclitaxel in NSCLC Patients with ECOG PS of 2. 11:S274-S274. 2016
- Clinical and Pathologic Characteristics of Bronchial Carcinoid Tumors: A Single Institution Review. 10:S749-S750. 2015
- Radionuclide Therapy with Meta-Iodo-Benzyl-Guanidine (MIBG) for Patients with MIBG Avid Pulmonary Carcinoid Tumors. 10:S633-S633. 2015
- nab-Paclitaxel/Carboplatin Followed By nab-Paclitaxel for NSCLC PS 2 (ABOUND.PS2). 10:S553-S553. 2015
Identity
International Standard Serial Number (ISSN)
- 1556-0864